Ubs Asset Management Americas Inc Biogen Inc. Transaction History

Ubs Asset Management Americas Inc

  • $477 Billion
  • Q2 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Biogen Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,743,209 shares of BIIB stock, worth $269 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,743,209
Previous 1,510,386 15.41%
Holding current value
$269 Million
Previous $207 Million 5.93%
% of portfolio
0.05%
Previous 0.05%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$113.38 - $135.49 $26.4 Million - $31.5 Million
232,823 Added 15.41%
1,743,209 $219 Million
Q1 2025

May 19, 2025
SELL
$133.43 - $153.27 $3.13 Million - $3.59 Million
-23,427 Reduced 1.53%
1,510,386 $207 Million
Q4 2024

Feb 14, 2025
BUY
$146.47 - $191.55 $55.8 Million - $73 Million
381,122 Added 33.06%
1,533,813 $235 Million
Q3 2024

Nov 14, 2024
BUY
$189.07 - $236.8 $3.57 Million - $4.48 Million
18,905 Added 1.67%
1,152,691 $223 Million
Q2 2024

Aug 13, 2024
BUY
$190.52 - $236.72 $30.8 Million - $38.3 Million
161,643 Added 16.63%
1,133,786 $263 Million
Q1 2024

May 15, 2024
SELL
$212.02 - $267.71 $9 Million - $11.4 Million
-42,440 Reduced 4.18%
972,143 $210 Million
Q4 2023

Feb 14, 2024
SELL
$222.59 - $267.94 $11.3 Million - $13.6 Million
-50,935 Reduced 4.78%
1,014,583 $263 Million
Q3 2023

Nov 13, 2023
SELL
$253.3 - $285.89 $12.4 Million - $14 Million
-49,084 Reduced 4.4%
1,065,518 $274 Million
Q1 2023

May 15, 2023
BUY
$256.56 - $292.34 $5.24 Million - $5.97 Million
20,411 Added 1.87%
1,114,602 $310 Million
Q4 2022

Feb 14, 2023
SELL
$252.44 - $306.72 $5.62 Million - $6.83 Million
-22,265 Reduced 1.99%
1,094,191 $303 Million
Q3 2022

Nov 14, 2022
SELL
$194.69 - $268.46 $7.94 Million - $11 Million
-40,807 Reduced 3.53%
1,116,456 $298 Million
Q2 2022

Aug 12, 2022
SELL
$187.54 - $223.02 $1.13 Million - $1.35 Million
-6,049 Reduced 0.52%
1,157,263 $236 Million
Q1 2022

May 16, 2022
BUY
$193.77 - $244.14 $777,017 - $979,001
4,010 Added 0.35%
1,163,312 $245 Million
Q4 2021

Feb 14, 2022
SELL
$223.92 - $287.77 $19.2 Million - $24.7 Million
-85,684 Reduced 6.88%
1,159,302 $278 Million
Q3 2021

Nov 15, 2021
BUY
$282.99 - $369.05 $30.1 Million - $39.3 Million
106,513 Added 9.36%
1,244,986 $352 Million
Q2 2021

Aug 16, 2021
SELL
$259.0 - $414.71 $5.52 Million - $8.84 Million
-21,311 Reduced 1.84%
1,138,473 $394 Million
Q1 2021

May 14, 2021
SELL
$242.95 - $284.63 $7.44 Million - $8.71 Million
-30,613 Reduced 2.57%
1,159,784 $324 Million
Q4 2020

Mar 01, 2021
SELL
$236.26 - $355.63 $32.9 Million - $49.5 Million
-139,251 Reduced 10.47%
1,190,397 $291 Million
Q3 2020

Nov 13, 2020
BUY
$264.77 - $305.71 $5.53 Million - $6.38 Million
20,877 Added 1.6%
1,329,648 $377 Million
Q2 2020

Aug 14, 2020
BUY
$258.66 - $342.55 $55.4 Million - $73.4 Million
214,313 Added 19.58%
1,308,771 $350 Million
Q1 2020

May 15, 2020
SELL
$268.85 - $341.04 $3.47 Million - $4.4 Million
-12,893 Reduced 1.16%
1,094,458 $346 Million
Q4 2019

Feb 14, 2020
SELL
$220.06 - $304.07 $11.4 Million - $15.8 Million
-51,798 Reduced 4.47%
1,107,351 $329 Million
Q3 2019

Nov 14, 2019
SELL
$217.44 - $243.88 $48.1 Million - $54 Million
-221,230 Reduced 16.03%
1,159,149 $270 Million
Q2 2019

Aug 15, 2019
BUY
$219.29 - $241.72 $18.4 Million - $20.3 Million
84,065 Added 6.48%
1,380,379 $0
Q1 2019

May 14, 2019
BUY
$216.71 - $338.96 $33.1 Million - $51.7 Million
152,648 Added 13.35%
1,296,314 $0
Q4 2018

Feb 13, 2019
SELL
$278.5 - $352.75 $86.1 Million - $109 Million
-309,228 Reduced 21.28%
1,143,666 $344 Million
Q3 2018

Nov 14, 2018
BUY
$293.51 - $383.83 $103 Million - $135 Million
351,238 Added 31.88%
1,452,894 $0
Q2 2018

Aug 14, 2018
BUY
$257.52 - $306.91 $25.9 Million - $30.8 Million
100,390 Added 10.03%
1,101,656 $0
Q1 2018

May 14, 2018
BUY
$260.13 - $367.91 $43.8 Million - $62 Million
168,497 Added 20.23%
1,001,266 $0
Q4 2017

Feb 09, 2018
BUY
$307.64 - $344.58 $12.6 Million - $14.1 Million
40,922 Added 5.17%
832,769 $0
Q3 2017

Nov 13, 2017
BUY
$281.15 - $329.69 $223 Million - $261 Million
791,847
791,847 $0

Others Institutions Holding BIIB

# of Institutions
1,021
Shares Held
131M
Call Options Held
2.87M
Put Options Held
2.57M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.2B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email